lobbying_activities: 669079

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
669079 4572c897-14c0-4361-bacf-4207c1713aac Q3 GOODWIN PROCTER LLP 79756 TEVA PHARMACEUTICALS USA INC 2008 third_quarter PHA S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT (ALL PROVISIONS FOR ALL BILLS) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-16T11:36:53-04:00